The US Trade Representative’s review has raised concerns about India’s intellectual property enforcement standards. Indian officials contest the review’s legitimacy and stress that their IP laws prioritise public interest. The results may impact India’s investment climate and global image.
Read more about OCR: Credibility of India’s Intellectual Property Enforcement in QuestionTag: Patent Law india
Drug Humira turns Rheumatic for Abbott Biotechnology
The Indian Patent Office set aside Abbott Biotechnology’s Humira patent after Glenmark’s pre-grant opposition, citing lack of inventive step and insufficient disclosure. This legal dispute underscores ongoing challenges to Humira patents both in India and globally.
Read more about Drug Humira turns Rheumatic for Abbott BiotechnologyLaws of Nature / State of Art Interface
This post explores how the laws of nature exclusion shapes patent eligibility, especially in biotechnology. It discusses key judicial decisions and the impact of state of the art on the scope of this legal doctrine.
Read more about Laws of Nature / State of Art Interface